Novan Therapeutics Receives $30,409,735 New Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8526c094-78c9-4309-a5f0-d7290b9f85b8 - Date
12/16/2015 - Company Name
Novan Therapeutics - Mailing Address
4222 Emperor Boulevard Durham, NC 27703 USA - Company Description
Novan uses a licensed nitric oxide technology, developed at the lab of Schoenfisch, to give medical devices an antimicrobial coating, helping to fight bacteria. - Website
http://www.novantherapeutics.com - Transaction Type
Venture Equity - Transaction Amount
$30,409,735 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. - M&A Terms
- Venture Investor
Undisclosed
